Talis Biomedical Corp

TLISDelisted Sep 20, 2024

Industry: Laboratory Analytical Instruments
SEC CIK: 0001584751

SEC filings (opens in a new tab)

Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Talis Biomedical Corp changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of TLIS: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	38	47	+9
Shares	19.1M	17.5M	−1.56M (−8.2%)
Value	$119.2M	$70.2M	−$49.0M (−41.1%)

New holders (14)

Institutions that held Talis Biomedical Corp at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to TLIS in Q4 2021
Institution	Shares	Value	% of portfolio
Greenlight Capital Inc	1,569,300	$6.29M	0.38%
Two Sigma Investments, LP	78,628	$315.0K	0.00%
Bridgeway Capital Management, LLC	32,500	$130.0K	0.00%
Two Sigma Advisers, LP	24,900	$100.0K	0.00%
Golden State Equity Partners	22,133	$89.0K	0.04%
Susquehanna International Group, LLP	12,217	$49.0K	0.00%
Tudor Investment Corp Et Al	10,000	$40.0K	0.00%
Wells Fargo & Company	8,023	$32.0K	0.00%
UBS Group AG	7,479	$30.0K	0.00%
Simplex Trading, LLC	1,231	$4.00K	0.00%
Captrust Financial Advisors	828	$3.00K	0.00%
The PNC Financial Services Group, Inc.	275	$1.00K	0.00%
Toronto Dominion Bank	2	$0	0.00%
Ellevest, Inc.	41	$0	0.00%

Sold out (5)

Institutions that held Talis Biomedical Corp at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of TLIS in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Boxer Capital, LLC	1,550,998	$9.69M
Nicholas Investment Partners, LP	989,090	$6.18M
Janney Montgomery Scott LLC	10,000	$62.0K
Chicago Partners Investment Group LLC	10,000	$54.0K
Group One Trading, L.P.	825	$5.00K